PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Putnam BioRevolution ETF (SYNB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US7467298052

Issuer

Putnam

Inception Date

Sep 29, 2022

Leveraged

1x

Index Tracked

No Index (Active)

Asset Class

Equity

Asset Class Size

Large-Cap

Asset Class Style

Growth

Expense Ratio

SYNB features an expense ratio of 0.70%, falling within the medium range.


Expense ratio chart for SYNB: current value at 0.70% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.70%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
SYNB vs. IYH SYNB vs. ARKG SYNB vs. SPY
Popular comparisons:
SYNB vs. IYH SYNB vs. ARKG SYNB vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Putnam BioRevolution ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-6.97%
10.30%
SYNB (Putnam BioRevolution ETF)
Benchmark (^GSPC)

Returns By Period

Putnam BioRevolution ETF had a return of 1.12% year-to-date (YTD) and 0.81% in the last 12 months.


SYNB

YTD

1.12%

1M

-0.69%

6M

-7.87%

1Y

0.81%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of SYNB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.03%1.12%
2024-1.80%5.96%2.48%-5.30%5.05%1.07%3.56%2.11%0.20%-4.72%-0.98%-4.54%2.32%
20235.64%-3.80%3.33%0.53%-2.73%4.01%3.15%-0.56%-6.12%-7.02%9.24%7.34%12.13%
20223.27%7.13%-5.33%4.74%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SYNB is 8, meaning it’s performing worse than 92% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SYNB is 88
Overall Rank
The Sharpe Ratio Rank of SYNB is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of SYNB is 77
Sortino Ratio Rank
The Omega Ratio Rank of SYNB is 77
Omega Ratio Rank
The Calmar Ratio Rank of SYNB is 88
Calmar Ratio Rank
The Martin Ratio Rank of SYNB is 88
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Putnam BioRevolution ETF (SYNB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for SYNB, currently valued at 0.03, compared to the broader market0.002.004.000.031.74
The chart of Sortino ratio for SYNB, currently valued at 0.14, compared to the broader market-2.000.002.004.006.008.0010.0012.000.142.36
The chart of Omega ratio for SYNB, currently valued at 1.02, compared to the broader market0.501.001.502.002.503.001.021.32
The chart of Calmar ratio for SYNB, currently valued at 0.04, compared to the broader market0.005.0010.0015.000.042.62
The chart of Martin ratio for SYNB, currently valued at 0.09, compared to the broader market0.0020.0040.0060.0080.00100.000.0910.69
SYNB
^GSPC

The current Putnam BioRevolution ETF Sharpe ratio is 0.03. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Putnam BioRevolution ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50SeptemberOctoberNovemberDecember2025February
0.03
1.74
SYNB (Putnam BioRevolution ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Putnam BioRevolution ETF provided a 0.72% dividend yield over the last twelve months, with an annual payout of $0.21 per share.


0.10%0.20%0.30%0.40%0.50%0.60%0.70%$0.00$0.05$0.10$0.15$0.2020232024
Dividends
Dividend Yield
PeriodTTM20242023
Dividend$0.21$0.21$0.02

Dividend yield

0.72%0.72%0.07%

Monthly Dividends

The table displays the monthly dividend distributions for Putnam BioRevolution ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.21$0.21
2023$0.02$0.02

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%SeptemberOctoberNovemberDecember2025February
-9.38%
0
SYNB (Putnam BioRevolution ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Putnam BioRevolution ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Putnam BioRevolution ETF was 14.92%, occurring on Oct 27, 2023. Recovery took 36 trading sessions.

The current Putnam BioRevolution ETF drawdown is 9.38%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-14.92%Jul 27, 202366Oct 27, 202336Dec 19, 2023102
-11.13%Sep 20, 202464Dec 19, 2024
-8.14%Feb 3, 202325Mar 10, 202367Jun 15, 202392
-7.65%Mar 22, 202420Apr 19, 202418May 15, 202438
-7.23%Dec 5, 202211Dec 19, 202229Feb 1, 202340

Volatility

Volatility Chart

The current Putnam BioRevolution ETF volatility is 4.11%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%SeptemberOctoberNovemberDecember2025February
4.11%
3.07%
SYNB (Putnam BioRevolution ETF)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab